Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcoma
Arjun Pant, Catherine Yip, Bhuvitha Chagantipati, Milena Mattioli, Virginia M. Kelly, Eesa Noaman, Arianna Kahler‐Quesada, Brady Grano-Mickelsen, Sydney Jackson, Peter L. Choyke, Hisataka Kobayashi, Costas G. Hadjipanayis, Lauren Taylor Rosenblum, Marcus M. Malek, Gary Kohanbash
This study combines GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy to enhance cytotoxicity and reduce light-dose requirements in neuroblastoma and osteosarcoma.
bioRxiv · Sep 3, 2026 · PreprintCancer Biology